Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Hustinx

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2004
18F-FDG PET in children with lymphomasGisele Depas, Caroline De Barsy, Guy Jerusalem, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 9, 2014
Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patientsJohan Stender, Ron Kupers, Anders Rodell, et al.
The British Journal of Radiology|May 6, 2016
(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational statusPierre Lovinfosse, Benjamin Koopmansch, Frederic Lambert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2015
18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: correlation with histopathologyNadia Withofs, Nicolas Signolle, Joan Somja, et al.
Plos One|May 7, 2021
The application of a workflow integrating the variable reproducibility and harmonizability of radiomic features on a phantom datasetAbdalla Ibrahim, Turkey Refaee, Ralph T H Leijenaar, et al.
Journal of Applied Clinical Medical Physics|September 11, 2014
FDG PET/CT for rectal carcinoma radiotherapy treatment planning: comparison of functional volume delineation algorithms and clinical challengesNadia Withofs, Claire Bernard, Catherine Van der Rest, et al.
Clinical and Translational Radiation Oncology|January 30, 2024
Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experienceFrançois Lucia, Carole Mievis, Nicolas Jansen, et al.
EJNMMI Research|May 28, 2024
Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [<sup>18</sup>F]FDG PET/CT in patients with newly diagnosed multiple myelomaSilvano Marchiori, François Cousin, Iraklis Papadopoulos, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 13, 2018
"NOTA-PRGD<sub>2</sub> and NODAGA-PRGD<sub>2</sub> : Bioconjugation, characterization, radiolabelling, and design space"Mallory Salvé, Hermane T Avohou, Jean-Christophe M Monbaliu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 23, 2015
[(18)F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinomaNadia Withofs, Philippe Martinive, Jean Vanderick, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2004
18F-FDG PET in children with lymphomasGisele Depas, Caroline De Barsy, Guy Jerusalem, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 9, 2014
Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patientsJohan Stender, Ron Kupers, Anders Rodell, et al.
The British Journal of Radiology|May 6, 2016
(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational statusPierre Lovinfosse, Benjamin Koopmansch, Frederic Lambert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2015
18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: correlation with histopathologyNadia Withofs, Nicolas Signolle, Joan Somja, et al.
Plos One|May 7, 2021
The application of a workflow integrating the variable reproducibility and harmonizability of radiomic features on a phantom datasetAbdalla Ibrahim, Turkey Refaee, Ralph T H Leijenaar, et al.
Journal of Applied Clinical Medical Physics|September 11, 2014
FDG PET/CT for rectal carcinoma radiotherapy treatment planning: comparison of functional volume delineation algorithms and clinical challengesNadia Withofs, Claire Bernard, Catherine Van der Rest, et al.
Clinical and Translational Radiation Oncology|January 30, 2024
Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experienceFrançois Lucia, Carole Mievis, Nicolas Jansen, et al.
EJNMMI Research|May 28, 2024
Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [<sup>18</sup>F]FDG PET/CT in patients with newly diagnosed multiple myelomaSilvano Marchiori, François Cousin, Iraklis Papadopoulos, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 13, 2018
"NOTA-PRGD<sub>2</sub> and NODAGA-PRGD<sub>2</sub> : Bioconjugation, characterization, radiolabelling, and design space"Mallory Salvé, Hermane T Avohou, Jean-Christophe M Monbaliu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 23, 2015
[(18)F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinomaNadia Withofs, Philippe Martinive, Jean Vanderick, et al.
Pageof 17